Related Topics
New tool can help guide COVID-19 vaccine distribution
A new data-driven tool will help state and county decisionmakers in the U.S. plan for the distribution of coronavirus vaccines to priority populations.
Expert: Coronavirus vaccine approval could come by end of 2020
The odds are “reasonably high” that a coronavirus vaccine will be approved before the end of the year, according to Harvard Chan School's Howard Koh.
Viewpoint: Prioritizing racial minorities for COVID-19 vaccines
An op-ed co-authored by Dean Michelle Williams addresses the issue of race and vaccine allocation in the U.S.
Op-ed: A call to build trust in COVID-19 vaccination
Howard Koh of Harvard Chan School outlined five ways for political leaders to build trust in a coronavirus vaccine.
Frontlines Fall 2020
Quick updates about the latest public health news from across the School and beyond.
The Connected Crisis
The COVID-19 pandemic has inspired new research directions across the School
HPV vaccination rates increasing in U.S., but still fall short of goals
Rates of vaccination for the human papillomavirus are on the rise among children in the U.S., but still fall short of national goals.
‘The key ingredient of any vaccine is trust’
Harvard Chan School's Barry Bloom discusses the coronavirus vaccine development process and how to persuade people to get vaccinated.
Assessing six months of pandemic response in Massachusetts
Research fellow Stephen Kissler discussed the past six months of coronavirus response in Massachusetts as well as what to expect in the next six.
Coronavirus vaccine candidates show promise
Positive early trial results from two coronavirus vaccine candidates are “very exciting,” according to Harvard Chan School's Barry Bloom.
